Mounjaro contains the medicine tirzepatide. It’s a once-weekly injection used to support weight loss in eligible patients, and it works in a similar way to Wegovy by reducing appetite and helping people feel fuller for longer.
Tirzepatide activates two receptors in the body:
GLP-1 (glucagon-like peptide-1)
GIP (glucose-dependent insulinotropic polypeptide)
These receptors are involved in regulating blood sugar levels and curbing appetite, which can help reduce hunger and cravings over time.
Mounjaro at a glance
~20–25% weight loss after the first year (varies by individual and depends on dose, adherence and lifestyle changes)
Once-weekly injection
Maintenance doses: 5mg, 10mg, 15mg weekly (your prescriber will recommend what’s right for you)
Typical age limit: 18+ (subject to clinical assessment and eligibility)
Comments
0 comments
Article is closed for comments.